This finding is consistent with previous reports that CPA4 was overexpressed in NSCLC, gastric cancer, and pancreatic cancer.11, 12, 14 Further, loss and gain of function experiments demonstrated that CPA4 promoted lung cancer cell growth. The gene discussed is CPA4; the disease is non-small cell lung carcinoma.